You know quarterly revenue will be rubbish - as BOOM2 trials only started December. I suspect even lower revenue than last quarter. But who cares as was all about getting an update on teh success of BOOM2 trials which material agreements indicates latter.
Wait and see but can't see this is bad from here, given where share price is, but more about how good it can be.
IAM Price at posting:
1.6¢ Sentiment: None Disclosure: Held
